Sinew Pharma Inc
SINEW PHARMA INC.(stock code: 6634.TWO) is a publicly-listed biotech company dedicated on the development of therapeutic products for solving urgent and important unmet medical needs. SINEW aspires to become a leading pharmaceutical company by actively engaging in R&D for drug development of metabolic dysfunction-associated steatohepatitis, MASH (formerly known as non-alcoholic steatohepatitis, NASH) as well as for the world's first non-hepatotoxic acetaminophen. Current pipeline includes six products, two of which are dedicated to MASH treatment, three aim to address liver toxicity issues arising from the widely used painkiller acetaminophen and its combinations (e.g, with a non-addictive kappa-opioid for postoperative pain management), and one serves as an antidote for acetaminophen poisoning.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
12
11 to 50 range
Open roles
2
across 1 depts
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
81
organic / mo
Hiring · 2 open positions across 1 departments
Sign up free to see all 8 verified contacts at Sinew Pharma Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
Showing 1 of 8 verified contacts
Top roles at Sinew Pharma Inc
6 distinct titles indexed · top 6 shown.
- 2director of business development
- 2research fellow
- 1deputy director
- 1deputy director of r & d
- 1director of quantitative analytical department
- 1research and development scientist
Sign up to unlock all 8 contacts at Sinew Pharma Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Sinew Pharma Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.